Experienced in Antiphospholipid Syndrome

Dr. Terry Gernsheimer

Hematology
Seattle Cancer Care Alliance, 825 Eastlake Avenue East, 
Seattle, WA 
Offers Telehealth
43 Years of Experience
Experienced in Antiphospholipid Syndrome
Seattle Cancer Care Alliance, 825 Eastlake Avenue East, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Terry Gernsheimer is a Hematologist in Seattle, Washington. Dr. Gernsheimer has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Antiphospholipid Syndrome. Her top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Blood Clots, and Splenectomy.

Her clinical research consists of co-authoring 62 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in WA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Enrollment Status: Completed
Publish Date: May 25, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3

62 Total Publications

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Journal: American journal of hematology
Published: October 29, 2024
Similar Doctors
Experienced in Antiphospholipid Syndrome
Dr. David A. Garcia
Hematology
Experienced in Antiphospholipid Syndrome
Dr. David A. Garcia
Hematology

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (2.1 miles away)
206-598-4333
Languages Spoken:
English, Castilian, Filipino, French, German, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Garcia is a Hematologist in Seattle, Washington. Dr. Garcia is rated as an Advanced provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Garcia is currently accepting new patients.

David M. Aboulafia
Advanced in Antiphospholipid Syndrome
Dr. David M. Aboulafia
Hematology Oncology | Hematology | Oncology
Advanced in Antiphospholipid Syndrome
Dr. David M. Aboulafia
Hematology Oncology | Hematology | Oncology

Virginia Mason Medical Center

925 Seneca St, 
Seattle, WA 
 (1.7 miles away)
206-223-6600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Aboulafia is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Aboulafia is rated as a Distinguished provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Anal Cancer, Kaposi Sarcoma, B-Cell Lymphoma, and Splenectomy. Dr. Aboulafia is currently accepting new patients.

Experienced in Antiphospholipid Syndrome
Dr. Jacob E. Mathew
Hematology | Oncology
Experienced in Antiphospholipid Syndrome
Dr. Jacob E. Mathew
Hematology | Oncology

Franciscan Medical Group

2720 Clare Ave, Suite A, 
Bremerton, WA 
 (13.6 miles away)
360-479-6154
Languages Spoken:
English, Farsi, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Jacob Mathew is a Hematologist and an Oncologist in Bremerton, Washington. Dr. Mathew is rated as a Distinguished provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Pleuropulmonary Blastoma, Osteotomy, and Bone Marrow Aspiration. Dr. Mathew is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gernsheimer's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile